Diabetes and the risk of osteonecrosis of the jaw.
Favus
Murray J
MJ
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use; D048909:Diabetes Complications; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced*; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D010020:Osteonecrosis / Q000139:chemically induced*; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy; D012307:Risk Factors
D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates